Abstract:Photodynamic therapy (PDT) is a clinically approved therapeutic modality that has shown great potential for the treatment of cancers owing to its excellent spatiotemporal selectivity and inherently noninvasive nature. However, PDT has not reached its full potential, partly due to the lack of ideal photosensitizers. A common molecular design strategy for effective photosensitizers is to incorporate heavy atoms into photosensitizer structures, causing concerns about elevated dark toxicity, short triplet-state lifetimes, poor photostability, and the potentially high cost of heavy metals. To address these drawbacks, a significant advance has been devoted to developing advanced smart photosensitizers without the use of heavy atoms to better fit the clinical requirements of PDT. Over the past few years, heavy-atom-free nonporphyrinoid photosensitizers have emerged as an innovative alternative class of PSs due to their superior photophysical and photochemical properties and lower expense. Heavy-atom-free nonporphyrinoid photosensitizers have been widely explored for PDT purposes and have shown great potential for clinical oncologic applications. Although many review articles about heavy-atom-free photosensitizers based on porphyrinoid structure have been published, no specific review articles have yet focused on the heavy-atom-free nonporphyrinoid photosensitizers.In this account, the specific concept related to heavy-atom-free photosensitizers and the advantageous properties of heavy-atom-free photosensitizers for cancer theranostics will be briefly introduced. In addition, recent progress in the development of heavy-atom-free photosensitizers, ranging from molecular design approaches to recent innovative types of heavy-atom-free nonporphyrinoid photosensitizers, emphasizing our own research, will be presented. The main molecular design approaches to efficient heavy-atom-free PSs can be divided into six groups: (1) the approach based on traditional tetrapyrrole structures, (2) spin-orbit charge-transfer intersystem crossing (SOCT-ISC), (3) reducing the singlet-triplet energy gap (Δ<i>E</i><sub>ST</sub>), (4) the thionation of carbonyl groups of conventional fluorophores, (5) twisted π-conjugation system-induced intersystem crossing, and (6) radical-enhanced intersystem crossing. The innovative types of heavy-atom-free nonporphyrinoid photosensitizers and their applications in cancer diagnostics and therapeutics will be discussed in detail in the third section. Finally, the challenges that need to be addressed to develop optimal heavy-atom-free photosensitizers for oncologic photodynamic therapy and a perspective in this research field will be provided. We believe that this review will provide general guidance for the future design of innovative photosensitizers and spur preclinical and clinical studies for PDT-mediated cancer treatments.

Recent Development of Heavy Atom-Free Triplet Photosensitizers for Photodynamic Therapy

Heavy Atom-Free Triplet Photosensitizers: Molecular Structure Design, Photophysical Properties and Application in Photodynamic Therapy

First-principles design of heavy-atom-free singlet oxygen photosensitizers for photodynamic therapy

Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer

Highly Efficient Photosensitizers with Molecular Vibrational Torsion for Cancer Photodynamic Therapy

Triplet Photosensitizers: from Molecular Design to Applications

Achieving Beyond 100% Triplet State Generation with Singlet Fission Strategy for High-Performance Photosensitizer Design

Regulating 1 O 2 generation from heavy-atom-free triplet photosensitizers based on thiophene-fused BODIPY

Recent Advances of Transition Ir(III) Complexes As Photosensitizers for Improved Photodynamic Therapy

Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy

Spin-Orbit Charge Transfer Intersystem Crossing (ISC) in Compact Electron Donor-Acceptor Dyads: ISC Mechanism and Application as Novel and Potent Photodynamic Therapy Reagents.

Access to the Triplet Excited States of Heavy-Atom-Free Boron-Dipyrromethene Photosensitizers via Radical Pair Intersystem Crossing for Image-Guided Tumor-Targeted Photodynamic Therapy

Recent Progress in Thermally Activated Delayed Fluorescence Photosensitizers for Photodynamic Therapy

Innovative Strategies For Enhanced Tumor Photodynamic Therapy

Recent Development of Heavy-Atom-free Triplet Photosensitizers: Molecular Structure Design, Photophysics and Application

Assembled Photosensitizers Applied for Enhanced Photodynamic Therapy

Radical Enhanced Intersystem Crossing Mechanism, Electron Spin Dynamics of High Spin States and Applications in Design of Heavy Atom-free Triplet Photosensitizers

Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy.

Triplet Photosensitizers Showing Strong Absorption of Visible Light and Long-Lived Triplet Excited States and Application in Photocatalysis: A Mini Review

New Cy5 Photosensitizers for Cancer Phototherapy: a Low Singlet-Triplet Gap Provides High Quantum Yield of Singlet Oxygen.

Radical Enhanced Intersystem Crossing Mechanism, Electron Spin Dynamics of High Spin States and Their Applications in the Design of Heavy Atom-Free Triplet Photosensitizers.